Impact of reboxetine plus oxybutynin treatment for obstructive sleep apnea on cardiovascular autonomic modulation

The combination of noradrenergic (reboxetine) plus antimuscarinic (oxybutynin) drugs (reb-oxy) reduced obstructive sleep apnea (OSA) severity but no data are available on its effects on cardiac autonomic modulation. We sought to evaluate the impact of 1-week reb-oxy treatment on cardiovascular auton...

Descripción completa

Detalles Bibliográficos
Autores principales: Perger, Elisa, Castiglioni, Paolo, Faini, Andrea, Soranna, Davide, Zambon, Antonella, Rosa, Debora, Vicini, Stefano, Meriggi, Paolo, Pini, Laura, Baratto, Claudia, Caravita, Sergio, Azarbarzin, Ali, Parati, Gianfranco, Lombardi, Carolina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950422/
https://www.ncbi.nlm.nih.gov/pubmed/36823241
http://dx.doi.org/10.1038/s41598-023-29436-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9950422/
https://www.ncbi.nlm.nih.gov/pubmed/36823241
http://dx.doi.org/10.1038/s41598-023-29436-9

Ejemplares similares